The analgesic efficacy of etoricoxib compared with oxycodone/acetaminophen in an acute postoperative pain model: A randomized, double-blind clinical trial

Anesthesia and Analgesia

Volumn 99, Issue 3, 2004, Pages 807-815

  Chang, David J ^a   Desjardins, Paul J ^b,c   King, Thomas R ^a   Erb, Tara ^a   Geba, Gregory P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Premier Research   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DIAZEPAM; ETORICOXIB; FENTANYL; LIDOCAINE; METHOHEXITAL; MIDAZOLAM; NARCOTIC ANALGESIC AGENT; NITROUS OXIDE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PARACETAMOL; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GINGIVITIS; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; POSTEXTRACTION ALVEOLITIS; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TOOTH EXTRACTION; TREATMENT OUTCOME; VOMITING;

ACETAMINOPHEN; ACUTE DISEASE; ADULT; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; OXYCODONE; PAIN, POSTOPERATIVE; PYRIDINES; SULFONES;

EID: 4143133352     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000133141.75831.57     Document Type: Article

References (25)

1. Vane J. Towards a better aspirin. Nature 1994;367:215-6.
2. Riendeau D, Percival MD, Brideau C, et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther 2001;296:558-66.
3. Hunt RH, Harper S, Watson DJ, et al. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. Am J Gastroenterol 2003;98:1725-33.
4. Dallob A, Hawkey CT, Greenberg H, et al. Characterization of etoricoxib, a novel, selective COX-2 inhibitor. J Clin Pharmacol 2003;43:573-85.
5. Hunt RH, Harper S, Callegari P, et al. Complimentary studies of the gastrointestinal safety of the cyclooxygenase-2-selective inhibitor etoricoxib. Aliment Pharmacol Ther 2003;17:201-10.
6. Rodrigues AD, Halpin RA, Geer LA, et al. Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers. Drug Metab Dispos 2003;31:224-32.
7. Schumacher HR, Boice JA, Daikh DI, et al. Randomized double blind trial of etoricoxib and indometacin treatment of acute gouty arthritis. BMJ 2002;324:1488-92.
8. Matsumoto AK, Melian A, Mandel DR, et al. A randomized, controlled clinical trial of etoricoxib in the treatment of rheumatoid arthritis. J Rheumatol 2002;29:1581-2.
9. Collantes E, Curtis SP, Lee KW, et al. A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. BMC Fam Pract 2002;3:10.
10. Gottesdiener K, Schnitzer T, Fisher C, et al. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis. Rheumatology (Oxford) 2002;41:1052-61.
11. Leung AT, Malmstrom K, Gallacher AE, et al. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: a randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial. Curr Med Res Opin 2002;18:49-58.
12. Forbes JA. Oral surgery. In: Max MB, Portenoy RK, Laska EM, eds. Advances in pain research and therapy: the design of analgesia clinical trials. New York: Raven Press, 1991:347-74.
13. Haas D. An update on analgesics for the management of acute postoperative dental pain. J Can Dent Assoc 2002;68:476-82.
14. Fricke JR, Reynolds D. Double-masked, single-dose comparison of bromfenac sodium, acetaminophen plus oxycodone, and placebo after oral surgery. Curr Ther Res 1997;10:773-83.
15. Cooper S, Precheur H, Rauch D, et al. Evaluation of oxycodone and acetaminophen in the treatment of postoperative dental pain. Oral Surg 1980;6:496-501.
16. Oxycodone and acetaminophen [product information]. Chadds Ford, PA: Endo Pharmaceuticals, 2001.
17. Malmstrom K, Shahane A, Fricke JR, et al. MK-0663, an investigational COX-2 inhibitor: the effect in acute pain using the dental-impaction model. Arthritis Rheum 2000;43(Suppl 9):299.
18. Desjardins PJ, Black PM, Balm TK, et al. Onset of analgesia: further validation of a new stopwatch methodology. Clin Pharmacol Ther 1996;59:130.
19. Malmstrom K, Kotey P, Coughlin H, et al. Efficacy of etoricoxib, naproxen sodium, and acetaminophen/codeine in acute dental pain. Clin Pharmacol Ther 2001;69(Suppl 2):2.
20. Moore RA, Gavaghan D, Tramèr MR, et al. Size is everything: large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78:209-16.
21. Barden J, Edwards JE, McQuay HJ, et al. Single-dose oral celecoxib for postoperative pain. In: The Cochrane library. Issue 4. Chichester, UK: Wiley, 2003.
22. Barden J, Edwards JE, McQuay HJ, et al. Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol 2003;3:1.
23. Barden J, Edwards JE, McQuay HJ, et al. Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review. BMC Anesthesiol 2003;2:4.
24. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63:17-32.
25. Oderda GM, Evans RS, Lloyd J, et al. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manag 2003;25:276-83.